AAAAAA

   
Results: 1-21 |
Results: 21
AUTOLOGOUS BACKUP BM PBSC PRIOR TO ALLOGENEIC TRANSPLANTATION - A SURVEY OF 85 EUROPEAN CENTERS/
Authors: POTTINGER B CLARK A HOLYOAKE T TANSEY P COOK G FRANKLIN IM
Citation: B. Pottinger et al., AUTOLOGOUS BACKUP BM PBSC PRIOR TO ALLOGENEIC TRANSPLANTATION - A SURVEY OF 85 EUROPEAN CENTERS/, Bone marrow transplantation, 21, 1998, pp. 35-35
BUSULFAN AND MELPHALAN CONDITIONING FOR AUTOLOGOUS BM PBSC TRANSPLANTATION IN MULTIPLE-MYELOMA/
Authors: CLARK A MITCHELL L ALCORN M TANSEY P COOK G FRANKLIN IM
Citation: A. Clark et al., BUSULFAN AND MELPHALAN CONDITIONING FOR AUTOLOGOUS BM PBSC TRANSPLANTATION IN MULTIPLE-MYELOMA/, Bone marrow transplantation, 21, 1998, pp. 349-349
IMPROVED ENGRAFTMENT KINETICS BUT INCREASED CHRONIC GVHD IN UNMANIPULATED ALLOGENEIC SIBLING PBSC TRANSPLANTATION
Authors: CLARK A COOK G CHOPRA R HOLYOAKE T ALCORN M GREEN R TANSEY P FRANKLIN IM
Citation: A. Clark et al., IMPROVED ENGRAFTMENT KINETICS BUT INCREASED CHRONIC GVHD IN UNMANIPULATED ALLOGENEIC SIBLING PBSC TRANSPLANTATION, British Journal of Haematology, 101, 1998, pp. 31-31
CISPLATIN, HIGH-DOSE CYTOSINE AND DEXAMETHASONE (DHAP) AS A PBSC MOBILIZATION REGIME IN PLASMA-CELL MYELOMA
Authors: DOUGLAS KW COOK G FARRELL E GREEN R ALCORN M PEARSON C TANSEY P FRANKLIN IM
Citation: Kw. Douglas et al., CISPLATIN, HIGH-DOSE CYTOSINE AND DEXAMETHASONE (DHAP) AS A PBSC MOBILIZATION REGIME IN PLASMA-CELL MYELOMA, British Journal of Haematology, 101, 1998, pp. 111-111
USE OF AUTOLOGOUS BACK UP BM PBSC FOLLOWING AUTOLOGOUS AND ALLOGENEICBMT - A SINGLE-CENTER EXPERIENCE AND SURVEY OF 85 EUROPEAN CENTERS/
Authors: POTTINGER B COOK G HOLYOAKE T WALKER M CAMPBELL M TANSEY P FRANKLIN IM
Citation: B. Pottinger et al., USE OF AUTOLOGOUS BACK UP BM PBSC FOLLOWING AUTOLOGOUS AND ALLOGENEICBMT - A SINGLE-CENTER EXPERIENCE AND SURVEY OF 85 EUROPEAN CENTERS/, British Journal of Haematology, 101, 1998, pp. 307-307
BUSULFAN AND MELPHALAN - A NOVEL AUTOGRAFT CONDITIONING REGIME IN MULTIPLE-MYELOMA
Authors: CLARK A MITCHELL L ALCORN M TANSEY P COOK G FRANKLIN IM
Citation: A. Clark et al., BUSULFAN AND MELPHALAN - A NOVEL AUTOGRAFT CONDITIONING REGIME IN MULTIPLE-MYELOMA, British Journal of Haematology, 101, 1998, pp. 308-308
TREATMENT OF CHRONIC MYELOID-LEUKEMIA IN FIRST CHRONIC PHASE WITH IDARUBICIN AND CYTARABINE - MOBILIZATION OF PHILADELPHIA-NEGATIVE PERIPHERAL-BLOOD STEM-CELLS
Authors: CHALMERS EA FRANKLIN IM KELSEY SR NEWLAND AC CLARK RE SPROUL AN CROTTY G MCCANN SR FIELDING A GOLDSTONE AH HEPPLESTONE A WATSON W SHARP RA TANSEY P
Citation: Ea. Chalmers et al., TREATMENT OF CHRONIC MYELOID-LEUKEMIA IN FIRST CHRONIC PHASE WITH IDARUBICIN AND CYTARABINE - MOBILIZATION OF PHILADELPHIA-NEGATIVE PERIPHERAL-BLOOD STEM-CELLS, British Journal of Haematology, 96(3), 1997, pp. 627-634
ALLOGENIC SIBLING PBSC TRANSPLANTATION RESULTS IN IMPROVED ENGRAFTMENT KINETICS BUT IS ASSOCIATED WITH A HIGH-INCIDENCE OF CHRONIC GVHD
Authors: CLARK A COOK G CHOPRA R HOLYOAKE T ALCORN M GREEN R TANSEY P FRANKLIN IM
Citation: A. Clark et al., ALLOGENIC SIBLING PBSC TRANSPLANTATION RESULTS IN IMPROVED ENGRAFTMENT KINETICS BUT IS ASSOCIATED WITH A HIGH-INCIDENCE OF CHRONIC GVHD, Blood, 90(10), 1997, pp. 1672-1672
COMPARATIVE-ANALYSIS OF LIPOSOMAL AND LIPID COMPLEX AMPHOTERICIN-B PREPARATIONS
Authors: CLARK A CHOPRA R MCKENDRICK S TANSEY P FRANKLIN IM
Citation: A. Clark et al., COMPARATIVE-ANALYSIS OF LIPOSOMAL AND LIPID COMPLEX AMPHOTERICIN-B PREPARATIONS, Blood, 90(10), 1997, pp. 2426-2426
IRON OVERLOAD AND LIVER DYSFUNCTION AFTER ALLOGENEIC OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: MCKAY PJ MURPHY JA CAMERON S BURNETT AK CAMPBELL M TANSEY P FRANKLIN IM
Citation: Pj. Mckay et al., IRON OVERLOAD AND LIVER DYSFUNCTION AFTER ALLOGENEIC OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 17(1), 1996, pp. 63-66
A PHASE I II TRIAL OF Z-DEX (ORAL IDARUBICIN AND DEXAMETHASONE), AN ORAL EQUIVALENT OF VAD, AS INITIAL THERAPY AT DIAGNOSIS OR PROGRESSION IN MULTIPLE-MYELOMA/
Authors: COOK G SHARP RA TANSEY P FRANKLIN IM
Citation: G. Cook et al., A PHASE I II TRIAL OF Z-DEX (ORAL IDARUBICIN AND DEXAMETHASONE), AN ORAL EQUIVALENT OF VAD, AS INITIAL THERAPY AT DIAGNOSIS OR PROGRESSION IN MULTIPLE-MYELOMA/, British Journal of Haematology, 93(4), 1996, pp. 931-934
ENGRAFTMENT KINETICS AND GRAFT-VERSUS-HOST DISEASE (GVHD) IN ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANTATION
Authors: COOK G PEARSON G GREEN R TANSEY P FRANKLIN IM
Citation: G. Cook et al., ENGRAFTMENT KINETICS AND GRAFT-VERSUS-HOST DISEASE (GVHD) IN ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANTATION, British Journal of Haematology, 93, 1996, pp. 151-151
Z-DEX (ORAL IDARUBICIN AND DEXAMETHASONE) IS EFFECTIVE INITIAL THERAPY IN THE TREATMENT OF PATIENTS WITH MULTIPLE-MYELOMA
Authors: COOK G IQBAL A RUSSELL NH SAMSON D SHARP RA TANSEY P FRANKLIN IM
Citation: G. Cook et al., Z-DEX (ORAL IDARUBICIN AND DEXAMETHASONE) IS EFFECTIVE INITIAL THERAPY IN THE TREATMENT OF PATIENTS WITH MULTIPLE-MYELOMA, British Journal of Haematology, 93, 1996, pp. 209-209
DETECTION OF MINIMAL RESIDUAL DISEASE USING KAPPA LAMBDA AND MESSENGER-RNA IN-SITU HYBRIDIZATION POST-AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) IN PATIENTS WITH MULTIPLE-MYELOMA/
Authors: COOK G LEE FD FARQUHARSON M PEARSON C TANSEY P FRANKLIN IM
Citation: G. Cook et al., DETECTION OF MINIMAL RESIDUAL DISEASE USING KAPPA LAMBDA AND MESSENGER-RNA IN-SITU HYBRIDIZATION POST-AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) IN PATIENTS WITH MULTIPLE-MYELOMA/, British Journal of Haematology, 93, 1996, pp. 210-210
PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) RESCUE FOLLOWING HIGH-DOSE CHEMOTHERAPY IN BREAST-CANCER - SATISFACTORY EARLY HEMATOPOIETIC RECONSTITUTION
Authors: EATOCK M COOK G FRANKLIN IM TANSEY P SOUKOP M DUNLOP D
Citation: M. Eatock et al., PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) RESCUE FOLLOWING HIGH-DOSE CHEMOTHERAPY IN BREAST-CANCER - SATISFACTORY EARLY HEMATOPOIETIC RECONSTITUTION, British Journal of Cancer, 73(8), 1996, pp. 25-25
DURATION OF CHRONIC PHASE CORRELATES WITH THE ABILITY TO MOBILIZE PHILADELPHIA NEGATIVE PERIPHERAL-BLOOD STEM-CELLS IN CHRONIC MYELOID-LEUKEMIA
Authors: CHALMERS EA FRANKLIN IM KELSEY SM NEWLAND AC CLARK RE SPROUL AM CROTTY G MCCANN SR FIELDING A GOLDSTONE AH HEPPLESTONE A WATSON W SHARP RA TANSEY P
Citation: Ea. Chalmers et al., DURATION OF CHRONIC PHASE CORRELATES WITH THE ABILITY TO MOBILIZE PHILADELPHIA NEGATIVE PERIPHERAL-BLOOD STEM-CELLS IN CHRONIC MYELOID-LEUKEMIA, Experimental hematology, 23(8), 1995, pp. 791-791
AN ORAL CHEMOTHERAPY REGIMEN, Z-DEX (ZAVEDOS CAPSULES (IDARUBICIN) AND DEXAMETHASONE) IS EFFECTIVE IN THE INITIAL THERAPY OF MULTIPLE-MYELOMA
Authors: COOK G FRANKLIN IM IQBAL A RUSSELL NH SAMSON D SHARP RA TANSEY P
Citation: G. Cook et al., AN ORAL CHEMOTHERAPY REGIMEN, Z-DEX (ZAVEDOS CAPSULES (IDARUBICIN) AND DEXAMETHASONE) IS EFFECTIVE IN THE INITIAL THERAPY OF MULTIPLE-MYELOMA, Blood, 86(10), 1995, pp. 730-730
MOBILIZATION OF PH-NEGATIVE PERIPHERAL-BLOOD STEM-CELLS IN CML WITH IDARUBICIN AND CYTARABINE
Authors: CHALMERS EA FRANKLIN IM KELSEY S CLARKE R SPROUL AM GOLDSTONE AH HEPPLESTONE A WATSON W SHARP S TANSEY P
Citation: Ea. Chalmers et al., MOBILIZATION OF PH-NEGATIVE PERIPHERAL-BLOOD STEM-CELLS IN CML WITH IDARUBICIN AND CYTARABINE, Bone marrow transplantation, 14, 1994, pp. 38-41
MOBILIZATION OF PH-NEGATIVE PROGENITORS INTO PERIPHERAL-BLOOD IN CHRONIC MYELOID-LEUKEMIA (CML) USING IDARUBICIN AND CYTARABINE
Authors: CHALMERS EA FRANKLIN IM KELSEY S CLARKE R SPROUL AM GOLDSTONE AH HEPPLESTONE A WATSON W SHARP S TANSEY P
Citation: Ea. Chalmers et al., MOBILIZATION OF PH-NEGATIVE PROGENITORS INTO PERIPHERAL-BLOOD IN CHRONIC MYELOID-LEUKEMIA (CML) USING IDARUBICIN AND CYTARABINE, Blood, 84(10), 1994, pp. 10000400-10000400
REESTABLISHMENT OF PHILADELPHIA-CHROMOSOME NEGATIVE HEMATOPOIESIS AFTER AUTOLOGOUS BMT FOLLOWING REJECTION OF MATCHED UNRELATED BMT IN CHRONIC MYELOID-LEUKEMIA
Authors: SPROUL A SALAMAT A TANSEY P CAMPBELL M BURNETT AK MILLS K DORAK T STEWART J RICHMOND L FRANKLIN IM
Citation: A. Sproul et al., REESTABLISHMENT OF PHILADELPHIA-CHROMOSOME NEGATIVE HEMATOPOIESIS AFTER AUTOLOGOUS BMT FOLLOWING REJECTION OF MATCHED UNRELATED BMT IN CHRONIC MYELOID-LEUKEMIA, British Journal of Haematology, 84, 1993, pp. 50-50
SURVIVORS AFTER ALLOGENEIC OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION HAVE MARKEDLY INCREASED SERUM FERRITIN ASSOCIATED WITH LIVER DYSFUNCTION RESPONSIVE TO VENESECTION
Authors: MCKAY P MURPHY J CAMERON S BURNETT AK CAMPBELL M TANSEY P FRANKLIN IM
Citation: P. Mckay et al., SURVIVORS AFTER ALLOGENEIC OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION HAVE MARKEDLY INCREASED SERUM FERRITIN ASSOCIATED WITH LIVER DYSFUNCTION RESPONSIVE TO VENESECTION, Blood, 82(10), 1993, pp. 10000418-10000418
Risultati: 1-21 |